482 related articles for article (PubMed ID: 24675552)
1. Gasdermin-B promotes invasion and metastasis in breast cancer cells.
Hergueta-Redondo M; Sarrió D; Molina-Crespo Á; Megias D; Mota A; Rojo-Sebastian A; García-Sanz P; Morales S; Abril S; Cano A; Peinado H; Moreno-Bueno G
PLoS One; 2014; 9(3):e90099. PubMed ID: 24675552
[TBL] [Abstract][Full Text] [Related]
2. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.
Hergueta-Redondo M; Sarrio D; Molina-Crespo Á; Vicario R; Bernadó-Morales C; Martínez L; Rojo-Sebastián A; Serra-Musach J; Mota A; Martínez-Ramírez Á; Castilla MÁ; González-Martin A; Pernas S; Cano A; Cortes J; Nuciforo PG; Peg V; Palacios J; Pujana MÁ; Arribas J; Moreno-Bueno G
Oncotarget; 2016 Aug; 7(35):56295-56308. PubMed ID: 27462779
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness.
Molina-Crespo Á; Cadete A; Sarrio D; Gámez-Chiachio M; Martinez L; Chao K; Olivera A; Gonella A; Díaz E; Palacios J; Dhal PK; Besev M; Rodríguez-Serrano M; García Bermejo ML; Triviño JC; Cano A; García-Fuentes M; Herzberg O; Torres D; Alonso MJ; Moreno-Bueno G
Clin Cancer Res; 2019 Aug; 25(15):4846-4858. PubMed ID: 31064780
[TBL] [Abstract][Full Text] [Related]
4. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
5. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells.
Oltra SS; Colomo S; Sin L; Pérez-López M; Lázaro S; Molina-Crespo A; Choi KH; Ros-Pardo D; Martínez L; Morales S; González-Paramos C; Orantes A; Soriano M; Hernández A; Lluch A; Rojo F; Albanell J; Gómez-Puertas P; Ko JK; Sarrió D; Moreno-Bueno G
Cell Death Differ; 2023 May; 30(5):1366-1381. PubMed ID: 36899106
[TBL] [Abstract][Full Text] [Related]
6. Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation.
Gámez-Chiachio M; Molina-Crespo Á; Ramos-Nebot C; Martinez-Val J; Martinez L; Gassner K; Llobet FJ; Soriano M; Hernandez A; Cordani M; Bernadó-Morales C; Diaz E; Rojo-Sebastian A; Triviño JC; Sanchez L; Rodríguez-Barrueco R; Arribas J; Llobet-Navás D; Sarrió D; Moreno-Bueno G
J Exp Clin Cancer Res; 2022 Sep; 41(1):285. PubMed ID: 36163066
[TBL] [Abstract][Full Text] [Related]
7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
8. Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the
Sarrio D; Rojo-Sebastián A; Teijo A; Pérez-López M; Díaz-Martín E; Martínez L; Morales S; García-Sanz P; Palacios J; Moreno-Bueno G
Front Cell Dev Biol; 2022; 10():813929. PubMed ID: 35281099
[TBL] [Abstract][Full Text] [Related]
9. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
[TBL] [Abstract][Full Text] [Related]
10. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
11. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
12. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
Yang X; Sun Y; Li H; Shao Y; Zhao D; Yu W; Fu J
Oncotarget; 2017 Apr; 8(16):26154-26168. PubMed ID: 28412731
[TBL] [Abstract][Full Text] [Related]
13. High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.
Pernodet N; Hermetet F; Adami P; Vejux A; Descotes F; Borg C; Adams M; Pallandre JR; Viennet G; Esnard F; Jouvenot M; Despouy G
Breast Cancer Res; 2012 Oct; 14(5):R136. PubMed ID: 23098186
[TBL] [Abstract][Full Text] [Related]
14. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
15. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
[TBL] [Abstract][Full Text] [Related]
16. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
17. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
[TBL] [Abstract][Full Text] [Related]
18. Alu-derived cis-element regulates tumorigenesis-dependent gastric expression of GASDERMIN B (GSDMB).
Komiyama H; Aoki A; Tanaka S; Maekawa H; Kato Y; Wada R; Maekawa T; Tamura M; Shiroishi T
Genes Genet Syst; 2010 Feb; 85(1):75-83. PubMed ID: 20410667
[TBL] [Abstract][Full Text] [Related]
19. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.
Patsialou A; Wang Y; Lin J; Whitney K; Goswami S; Kenny PA; Condeelis JS
Breast Cancer Res; 2012 Oct; 14(5):R139. PubMed ID: 23113900
[TBL] [Abstract][Full Text] [Related]
20. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
